247 related articles for article (PubMed ID: 10637579)
1. Anti-sleeping sickness drugs and cancer chemotherapy.
Barrett SV; Barrett MP
Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
[No Abstract] [Full Text] [Related]
2. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
3. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
Schlitzer M
Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
[No Abstract] [Full Text] [Related]
4. The treatment of human African trypanosomiasis.
Pépin J; Milord F
Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
[No Abstract] [Full Text] [Related]
5. [The return of sleeping sickness in an epidemic form: international action for drugs].
Kager PA
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
[TBL] [Abstract][Full Text] [Related]
6. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ
Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
[TBL] [Abstract][Full Text] [Related]
7. African sleeping sickness.
Hedley L; Fink D; Sparkes D; Chiodini PL
Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
[No Abstract] [Full Text] [Related]
8. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
Baker N; de Koning HP; Mäser P; Horn D
Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
[TBL] [Abstract][Full Text] [Related]
9. Killer coma: the evolving story of sleeping sickness treatment.
Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
[No Abstract] [Full Text] [Related]
10. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
Steverding D; Rushworth SA
Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
[TBL] [Abstract][Full Text] [Related]
11. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
Bouteille B; Darde ML; Pestre-Alexandre M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
[TBL] [Abstract][Full Text] [Related]
12. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
Simarro PP; Asumu PN
Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
[No Abstract] [Full Text] [Related]
13. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study.
Foulkes JR
Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195
[No Abstract] [Full Text] [Related]
14. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
Jennings FW; Rodgers J; Bradley B; Gettinby G; Kennedy PG; Murray M
Parasitol Int; 2002 Dec; 51(4):381-8. PubMed ID: 12421636
[TBL] [Abstract][Full Text] [Related]
15. Treatment of human African trypanosomiasis.
Dumas M; Bouteille B
Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
[No Abstract] [Full Text] [Related]
16. Existing chemotherapy and its limitations.
Gutteridge WE
Br Med Bull; 1985 Apr; 41(2):162-8. PubMed ID: 3161577
[No Abstract] [Full Text] [Related]
17. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in human African trypanosomiasis.
Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors.
Steverding D
Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707
[TBL] [Abstract][Full Text] [Related]
20. Protection of the sleeping sickness trypanosome from chemotherapy by different parts of the brain.
Raseroka BH; Ormerod WE
East Afr Med J; 1985 Jul; 62(7):452-8. PubMed ID: 4076024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
